Loading...
FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
Human epidermal growth factor receptor 1 or 2 (HER1/2), and fibroblast growth factor receptor 1 (FGFR1) signaling serve critical roles in the progression of breast cancer; however, cross-talk between HER1/2 and FGFR1 signaling has not been extensively studied. In the present study, the copy number v...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5950032/ https://ncbi.nlm.nih.gov/pubmed/29805554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8423 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|